Projects per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A PHASE IB/IIA, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED, MULTIPLE-ASCENDING DOSE, PARALLEL-GROUP STUDY TO INVESTIGATE THE SAFTEY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7126209 FOLLOWING INTRAVENOUS INFUSION IN PATIENTS WITH PRODROMAL OR MILD TO MODERATE ALZHEIMER'S DISEASE
Darby, D. & Kerris, J.
29/07/21 → 31/12/24
Project: Research
-
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Darby, D. & Wilson-Lee, P.
13/07/21 → 31/12/24
Project: Research
-
Active self-monitoring to prospectively detect treatment failure and define subclinical progression trajectories in multiple sclerosis: The ACTIVE-MS Program.
Van Der Walt, A., Butzkueven, H., Jokubaitis, V., Kolbe, S., Vogel, A. P., Stankovich, J., Butler, E., Macdonell, R. A. L. & Darby, D.
Trish Multiple Sclerosis Research Foundation
1/01/20 → 31/12/22
Project: Research
-
An Extension Study of ANAVEX2-73 in Patients with Mild to Moderate Alzheimer's Disease.
Darby, D., O'Brien, T. & Burn, K.
16/03/20 → 31/12/21
Project: Research
-
Active Participatory Health Monitoring in people with Multiple Sclerosis to improve treatment outcomes (Active-MS)
Butzkueven, H., Van Der Walt, A., Darby, D., Stankovich, J., Jokubaitis, V., Skibina, O., Marriott, M., Butler, E. & Gresle, M.
Department of Health (Australia)
1/07/19 → 30/06/21
Project: Research
-
Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive tests.
Merlo, D., Kalincik, T., Zhu, C., Gresle, M., Lechner-Scott, J., Kilpatrick, T., Barnett, M., Taylor, B., Buzzard, K., Darby, D., Butzkueven, H. & van der Walt, A., Feb 2022, In: Multiple Sclerosis and Related Disorders. 58, 6 p., 103393.Research output: Contribution to journal › Article › Research › peer-review
-
Association between cognitive trajectories and disability progression in patients with relapsing-remitting multiple sclerosis
Merlo, D., Stankovich, J., Bai, C., Kalincik, T., Zhu, C., Gresle, M., Lechner-Scott, J., Kilpatrick, T., Barnett, M., Taylor, B., Darby, D., Butzkueven, H. & Van Der Walt, A., 16 Nov 2021, In: Neurology. 97, 20, p. E2020-E2031 12 p.Research output: Contribution to journal › Article › Research › peer-review
-
A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia
Vivash, L., Malpas, C. B., Churilov, L., Walterfang, M., Brodtmann, A., Piguet, O., Ahmed, R. M., Bush, A. I., Hovens, C. M., Kalincik, T., Darby, D., Velakoulis, D. & O'Brien, T. J., Nov 2020, In: BMJ Open. 10, 11, 8 p., 040100.Research output: Contribution to journal › Article › Other › peer-review
Open Access2 Citations (Scopus) -
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis
Yam, C., Merlo, D., Stankovich, J., Darby, D., Gresle, M. M., Kalincik, T., Kilpatrick, T. J., Lechner-Scott, J., Taylor, B., Barnett, M., Butzkueven, H. & van der Walt, A., Aug 2020, In: Multiple Sclerosis and Related Disorders. 43, 7 p., 102212.Research output: Contribution to journal › Article › Research › peer-review
-
The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis
Merlo, D., Darby, D., Kalincik, T., Butzkueven, H. & van der Walt, A., Jul 2019, In: Therapeutic Advances in Neurological Disorders. 12, 15 p., UNSP 1756286419859183.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile8 Citations (Scopus)